Beta-2 adrenoreceptor agonists - short acting
Drug Safety Update
CSM has advised that potentially serious hypokalaemia may result from beta-2 agonist therapy. This may be exacerbated by corticosteroids, theophylline, diuretics and hypoxia. Plasma potassium may need to be monitored in severe asthma
December 2007: Short-acting beta-2 agonists may be associated with myocardial ischaemia
December 2014: Short-acting beta-2 agonists: restricted use for tocolysis in premature labour
July 2018: Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects
National Guidance:
NG80: Asthma diagnosis, monitoring and chronic asthma management, November 2017 (updated March 2021)
NG115: Chronic obstructive pulmonary disease in over 16s - diagnosis and management, December 2018 (updated July 2019)
BTS/SIGN British Guideline on the management of asthma, July 2019
| Pack | Price |
|---|---|
| 200 dose | £1.46 |
| Pack | Price |
|---|---|
| 200 dose | £6.02 |
| Pack | Price |
|---|---|
| 200 dose | £6.30 |
| Pack | Price |
|---|---|
| 200 dose | £3.31 |
| Pack | Price |
|---|---|
| 60 dose | £3.60 |
| Pack | Price |
|---|---|
| 20 unit dose | £4.33 |
| Pack | Price |
|---|---|
| 20 unit dose | £6.50 |
| Pack | Price |
|---|---|
| 5 ampoule | £1.91 |
| Pack | Price |
|---|---|
| 10 ampoule | £24.81 |
| Pack | Price |
|---|---|
| 100 dose | |
| 200 dose |
| Pack | Price |
|---|---|
| 20 unit dose | £6.21 |
| Pack | Price |
|---|---|
| 5 ampoule | £6.48 |